Regulatory & Legal

As GPS jamming becomes a critical threat, Northrop Grumman's new EGI-M system, powered by Green Hills software, ensures US jets stay on target.

A startup's novel 4D mammography system completes its first human trial, promising to detect cancer's molecular fingerprint and slash false positives.

Tom's Watch Bar partners with Sports Illustrated Tickets to let fans book their exact seats for big games, ending the game-day scramble for good.

With Q3 results and a leadership tour imminent, the luxury giant's performance will be a key barometer for a sector facing economic and competitive shifts.

A new HHS agenda reopens the door for controversial peptides, just as a wave of next-gen obesity drugs threatens to upend the entire market.

An $850M deal for an Arizona cobalt plant marks a pivotal US-Japan move to secure supply chains for defense, EVs, and advanced tech from rivals.

Schulich School of Business and CGI partner on an AI-powered certificate to address critical tech talent shortages and create new career pathways.

ThreatDown, the business-focused unit from Malwarebytes, has radically transformed its sales model, betting its future on a partner-first strategy.

A new report reveals 80% of security pros fear AI will cut jobs, while AI-powered malware and ransomware attacks continue to surge globally.

A new partnership between insurer Chubb and tech firm VCT introduces a proactive approach to prevent trial risks, enhancing patient safety and data integrity.

A shocking survey reveals most Americans believe eye disease has symptoms. A new campaign from Prevent Blindness aims to fight this dangerous misconception.

Ascidian Therapeutics to present first human safety data for its Stargardt disease drug, a new RNA editing technology with broad potential for genetic diseases.

As climate volatility rises, a new platform lets traders build their own forecasts, turning shared weather data into a secret weapon for market advantage.

South Korean AI firm HoneyNaps brings its FDA-cleared sleep diagnostic tech to Boston's biotech hub, aiming to disrupt the multi-billion dollar market.

A new survey reveals a massive gap between security goals and reality, as nearly all firms want microsegmentation but few successfully deploy it.

Zurich launches a major AI-focused capability center in Hyderabad, signaling a strategic shift to harness Indian tech talent for global insurance innovation.

Backed by activist investor Irenic Capital, a new $220M blank-check firm hits Nasdaq, aiming to acquire a target in the aerospace or industrial sectors.

Brazil's new antimicrobial rules are shaking up the livestock industry. See how Phibro is pivoting from growth promotion to a digital, therapeutic future.

The blank check company extends its merger deadline after an $850k sponsor deposit, facing a new owner, a cautious market, and a Nasdaq compliance notice.

VisionSys AI is in talks for a massive $90M investment to pivot to BCI tech, but with its stock down 96%, can this lifeline conquer the final frontier?